M Howard

11.0k total citations · 5 hit papers
50 papers, 9.3k citations indexed

About

M Howard is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, M Howard has authored 50 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 10 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Oncology. Recurrent topics in M Howard's work include T-cell and B-cell Immunology (25 papers), Immune Cell Function and Interaction (13 papers) and Immunotherapy and Immune Responses (13 papers). M Howard is often cited by papers focused on T-cell and B-cell Immunology (25 papers), Immune Cell Function and Interaction (13 papers) and Immunotherapy and Immune Responses (13 papers). M Howard collaborates with scholars based in United States, France and Australia. M Howard's co-authors include Tim R. Mosmann, Albert Zlotnik, Anne O’Garra, David Fiorentino, Kevin W. Moore, Tony Muchamuel, Satish Menon, Sílvia Passos Andrade, Paulo Vieira and W E Paul and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

M Howard

50 papers receiving 8.8k citations

Hit Papers

IL-10 inhibits cytokine production by activated macrophages 1982 2026 1996 2011 1991 1991 1982 1993 1994 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IL-10 inhibits cytokine production by activated macrophages
    1991 2.5k citations Albert Zlotnik, Tim R. Mosmann et al. The Journal of Immunology profile →
  2. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
    1991 1.6k citations Albert Zlotnik, Tim R. Mosmann et al. The Journal of Immunology profile →
  3. Identification of a T cell-derived b cell growth factor distinct from interleukin 2.
    1982 908 citations M Howard, Jeremy Farrar et al. The Journal of Experimental Medicine profile →
  4. Interleukin 10 protects mice from lethal endotoxemia.
    1993 678 citations M Howard, Tony Muchamuel et al. The Journal of Experimental Medicine profile →
  5. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.
    1994 449 citations Hiroshi Ishida, Tony Muchamuel et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Howard United States 31 6.2k 1.4k 1.4k 1.3k 903 50 9.3k
Judith G. Giri United States 30 6.5k 1.1× 1.7k 1.2× 1.4k 1.0× 1.1k 0.9× 437 0.5× 43 8.7k
G. J. Thorbecke United States 46 4.7k 0.8× 1.7k 1.2× 977 0.7× 675 0.5× 1.2k 1.4× 268 7.9k
Holly Cherwinski United States 29 6.4k 1.0× 2.5k 1.8× 1.6k 1.2× 1.3k 1.0× 697 0.8× 36 11.1k
M W Bond United States 27 7.6k 1.2× 2.5k 1.8× 1.5k 1.0× 1.6k 1.2× 1000 1.1× 31 12.7k
Martin Giedlin United States 23 5.3k 0.9× 2.0k 1.4× 1.4k 1.0× 1.1k 0.9× 525 0.6× 40 9.2k
Igal Gery United States 46 4.7k 0.8× 1.9k 1.3× 821 0.6× 1.0k 0.8× 641 0.7× 198 9.0k
Junming Le United States 29 3.0k 0.5× 1.2k 0.8× 966 0.7× 999 0.8× 485 0.5× 61 5.9k
R Chizzonite United States 45 4.7k 0.8× 2.2k 1.5× 1.1k 0.8× 830 0.7× 754 0.8× 72 8.2k
Richard K. Gershon United States 45 7.1k 1.2× 1.4k 1.0× 1.0k 0.7× 746 0.6× 1.3k 1.4× 162 9.6k
F Rousset France 38 5.6k 0.9× 1.1k 0.8× 1.1k 0.8× 572 0.5× 926 1.0× 69 8.5k

Countries citing papers authored by M Howard

Since Specialization
Citations

This map shows the geographic impact of M Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Howard more than expected).

Fields of papers citing papers by M Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Howard. The network helps show where M Howard may publish in the future.

Co-authorship network of co-authors of M Howard

This figure shows the co-authorship network connecting the top 25 collaborators of M Howard. A scholar is included among the top collaborators of M Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Howard. M Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Zheng, et al.. (2005). Cc chemokine receptor 9 (ccr9) antagonist ameliorates experimental ileitis and colitis. Gastroenterology. 128. 6 indexed citations
2.
Muchamuel, Tony, Satish Menon, Paul I. Pisacane, M Howard, & Debra A. Cockayne. (1997). IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. The Journal of Immunology. 158(6). 2898–2903. 136 indexed citations
3.
Sato, Shinichi, Ann S. Miller, M Howard, & Thomas F. Tedder. (1997). Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. The Journal of Immunology. 159(7). 3278–3287. 102 indexed citations
4.
Solvason, Nanette, Wei Wu, Nisha H. Kabra, et al.. (1996). Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.. The Journal of Experimental Medicine. 184(2). 407–417. 95 indexed citations
5.
Lund, Frances E., et al.. (1996). Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. The Journal of Immunology. 157(4). 1455–1467. 108 indexed citations
6.
Ishida, Hiroshi, Tony Muchamuel, Shimon Sakaguchi, et al.. (1994). Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.. The Journal of Experimental Medicine. 179(1). 305–310. 449 indexed citations breakdown →
7.
Cooke, Michael P., Andrew W. Heath, Kevan M. Shokat, et al.. (1994). Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells.. The Journal of Experimental Medicine. 179(2). 425–438. 279 indexed citations
8.
Howard, M, Tony Muchamuel, Sílvia Passos Andrade, & Satish Menon. (1993). Interleukin 10 protects mice from lethal endotoxemia.. The Journal of Experimental Medicine. 177(4). 1205–1208. 678 indexed citations breakdown →
9.
Ishida, H., et al.. (1992). Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells.. The Journal of Experimental Medicine. 175(5). 1213–1220. 168 indexed citations
10.
Rugo, Hope S., P O’Hanley, Alex Bishop, et al.. (1992). Local cytokine production in a murine model of Escherichia coli pyelonephritis.. Journal of Clinical Investigation. 89(3). 1032–1039. 81 indexed citations
11.
Go, Ning, Brian E. Castle, Rachel Barrett, et al.. (1990). Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells.. The Journal of Experimental Medicine. 172(6). 1625–1631. 423 indexed citations
12.
Lowenthal, John W., Brian E. Castle, J. Christiansen, et al.. (1988). Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells.. The Journal of Immunology. 140(2). 456–464. 214 indexed citations
13.
Lowenthal, John W., John Ransom, M Howard, & Albert Zlotnik. (1988). Up-regulation of interleukin 4 receptor expression on immature (Lyt-2-/L3T4-) thymocytes.. The Journal of Immunology. 140(2). 474–478. 23 indexed citations
14.
Stein, Paula, Patrice Dubois, David Yü Greenblatt, & M Howard. (1986). Induction of antigen-specific proliferation in affinity-purified small B lymphocytes: requirement for BSF-1 by type 2 but not type 1 thymus-independent antigens.. The Journal of Immunology. 136(6). 2080–2089. 29 indexed citations
15.
Howard, M, Patricia A. Pesavento, & Paul C. Stein. (1986). LPS-activated CBA/N mouse B cells respond to anti-Ig and a BSF-1-like factor.. The Journal of Immunology. 136(12). 4531–4537. 10 indexed citations
16.
Howard, M, S B Mizel, L Lachman, et al.. (1983). Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation.. The Journal of Experimental Medicine. 157(5). 1529–1543. 150 indexed citations
17.
Howard, M, Louis A. Matis, Thomas R. Malek, et al.. (1983). Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-I.. The Journal of Experimental Medicine. 158(6). 2024–2039. 106 indexed citations
18.
Swain, Susan L., M Howard, John W. Kappler, et al.. (1983). Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays.. The Journal of Experimental Medicine. 158(3). 822–835. 160 indexed citations
19.
Howard, M, Jeremy Farrar, Mary Hilfiker, et al.. (1982). Identification of a T cell-derived b cell growth factor distinct from interleukin 2.. The Journal of Experimental Medicine. 155(3). 914–923. 908 indexed citations breakdown →
20.
Shortman, Ken, John M. Fidler, Robert Schlegel, et al.. (1976). Subpopulations of B lymphocytes: physical separation of functionally distinct stages of B-cell differentiation.. PubMed. 5. 1–45. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith G. Giri Breakdown of academic impact, for papers by G. J. Thorbecke Breakdown of academic impact, for papers by Holly Cherwinski Breakdown of academic impact, for papers by M W Bond Breakdown of academic impact, for papers by Martin Giedlin Breakdown of academic impact, for papers by Igal Gery Breakdown of academic impact, for papers by Junming Le Breakdown of academic impact, for papers by R Chizzonite Breakdown of academic impact, for papers by Richard K. Gershon Breakdown of academic impact, for papers by F Rousset
Rankless by CCL
2026